So I'm thinking today on something that was said on one of my posts and that is... how will the health care bill kill jobs? So I decided to do a little research into the subject and came up with a lot of links but this one sticks out..and you thought conservative just listened to Glenn Beck, Rush Limbaugh and Mark Levin
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (5)
Medical device manufacturers have warned that a tax under the new health care overhaul on companies producing medical instruments and equipment will mean that jobs and manufacturing may have to be shifted out of the U.S. in order to secure already razor thin profits.
Beyond passing on costs to hospitals, surgeries, ambulance companies and the like, the options for the medical device industry are to cut research and development and then shift their production bases abroad.
Ernie Whiton, chief financial officer of Zoll Medical Corp., tells the Boston Herald “This bill is a jobs killer”.
“We could be forced to (move) manufacturing overseas if we can’t pass along these costs to our customers,” said Whiton.
Zoll, the leading manufacturer of heart defibrillators, employs around 650 people at its manufacturing facility in Massachusetts, and a further 1000 across the country.
“We believe that the tax will cost us somewhere between $5 million and $10 million a year,” Richard Packer, Zoll’s chairman and chief executive officer told The Washington Examiner this week. “Our profit in 2009 was $9.5 million.”
If there are any medical device manufacturer's out there..this might be the time to stand up and say this is either true or not true
- 1 vote
There is nothing "thin" razor or otherwise about the profit margins of MDMs. The enormous profits that they command are largely responsible for the every increasing cost of health care.
Taxing these high profit manufacturers are a good solution to paying for healthcare.
Year by year, today’s top companies show that dedication to the bottom line can help amass steady growth, with most of the top 30 companies posting healthy double-digit gains over the prior fiscal year.
1.
Johnson and Johnson
$17.7B
2.
GE Healthcare
$12.1B
3.
Medtronic
$10.1B
4.
Baxter International
$9.8B
4.
Cardinal Health
$9.8B
6.
Tyco Healthcare
$9.5B
7.
Siemens Medical Solutions
$9.2B
8.
Philips Medical Systems
$7.5B
9.
Boston Scientific
$6.3B
10.
Stryker
$4.9B
11.
B. Braun
$3.9B
12.
Guidant Corp.
$3.6B
13.
3M Healthcare
$3.5B
14.
Zimmer Holdings
$3.3B
15.
Becton, Dickinson & Co.
$3B
16.
St. Jude Medical
$2.9B
17.
Kodak Health Group
$2.7B
18.
Hospira
$2.6B
19.
Fresenius
$2.5B
20.
Smith & Nephew
$2.4B
21.
Synthes
$2.1B
22.
Alcon
$2B
23.
Biomet
$1.9B
24.
C. R. Bard
$1.8B
24.
Terumo
$1.8B
26.
Dentsply International
$1.7B
27.
Invacare
$1.5B
28.
Gambro
$1.4B
29.
Dräger Medical
$1.3B
30.
Varian Medical
$1.2B
http://www.mpo-mag.com/articles/2006/07/top-medical-device-companies-report
- 1 vote
Medical device manufacturers have warned that a tax under the new health care overhaul on companies producing medical instruments and equipment will mean that jobs and manufacturing may have to be shifted out of the U.S. in order to secure already razor thin profits.
Beyond passing on costs to hospitals, surgeries, ambulance companies and the like, the options for the medical device industry are to cut research and development and then shift their production bases abroad.
Of course Bill you conveniently ignore the fact that it costs a lot of Money to make these devices and by cutting into profits..what you actually do is send these people overseas to a more friendly corporate tax rate..What do you think has been happening over the last few years..
WASHINGTON, Jan. 11, 2011 /PRNewswire/ -- U.S. corporations are making fewer domestic hires and investing less in U.S. operations, due to cash trapped overseas, according to a recent survey from the Association for Financial Professionals (AFP). High U.S. corporate tax rates create an incentive for companies to leave cash abroad, often permanently.
In follow-up questions to AFP's recent 2011 Business Outlook Survey, 26% of respondents with operations abroad say that excessive U.S. corporate tax discourages their organization from bringing cash back to the U.S. and using it to invest in corporate growth in the form of new hires, capital investments, or research and development.
But of course I don't think I am dealing with the brightest bulb in the pack
Of course they are going to say that Joe. Unemployment and exportation of jobs is the hot button topic of the day. The MDMs have been making double digit increases in their profit margins every year for the last decade and they want to continue that trend. These taxes may flatten the exponential gain in their profit curve a little bit and they don't want to have to report that to their investors. They will say anything they can think of to put the fear of taxation into the American people.
It's a bluff and a lie.
- 1 vote
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |



